Skip to main content
Fig. 15 | BMC Cancer

Fig. 15

From: Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types

Fig. 15

CD276 expression is associated with the functions and treatment of GBM. A Single-cell analysis showed that CD276 is involved in regulating angiogenesis, proliferation, DNA damage and repair, EMT, inflammation, invasion and metastasis. B and C Data from the CancerSEA database showed that CD276 was correlated with various functions. D RT-qPCR was used to analyze CD276 and PCNA mRNA expression in patients with GBM compared with that in normal tissues. E and G The ROC plotter database was used to explore the relationship between CD276 expression and responses to chemotherapy in patients with GBM

Back to article page